USNA
USNA: Ding Xia discloses securities transactions
Ding Xia reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 3 transaction entries.
USNA
Ding Xia reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 3 transaction entries.
USNA
Fleming John Turman reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 2 transaction entries.
HSTM
REBROVICK LINDA reported Sale in HEALTHSTREAM INC: 12000 units of Common Stock, dated 2026-10-23. The full Form 4 contains 1 transaction entry.
USNA
Pelosi Peggie reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 3 transaction entries.
ZETA
Gerber Steven H. reported Exercise or conversion in Zeta Global Holdings Corp.: 226512 units of Class A Common Stock, dated 2026-10-22. The full Form 4 contains 6 transaction entries.
USNA
FULLER GILBERT A reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 2 transaction entries.
IMVT
Stout Jay S reported Sale in Immunovant, Inc.: 2595 units of Common Stock, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
ZETA
Greiner Christopher E reported Exercise or conversion in Zeta Global Holdings Corp.: 199155 units of Class A Common Stock, dated 2026-10-22. The full Form 4 contains 6 transaction entries.
USNA
Nixon J Scott reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 2 transaction entries.
USNA
Winssinger Frederic J reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 2 transaction entries.
ZETA
Ravella Satish reported Exercise or conversion in Zeta Global Holdings Corp.: 6017 units of Class A Common Stock, dated 2026-10-22. The full Form 4 contains 4 transaction entries.
NXG
Nelson Blake reported Purchase in NXG NextGen Infrastructure Income Fund: 900 units of Common Shares of Beneficial Interest, dated 2026-10-23. The full Form 4 contains 1 transaction entry.
FLD
McManus Matt reported Sale in Fold Holdings, Inc.: 2347 units of Common Stock, dated 2026-10-22. The full Form 4 contains 1 transaction entry.
KOD
BORGESON JOHN A. reported Exercise or conversion in Kodiak Sciences Inc.: 30000 units of Common Stock, dated 2026-10-21. The full Form 4 contains 10 transaction entries.
CRVO
Winton Matthew reported Grant or award in CervoMed Inc.: 19100 units of Stock Option (Right to Buy) (derivative), dated 2026-10-22. The full Form 4 contains 1 transaction entry.
USNA
WOOD TIMOTHY E reported Exercise or conversion in USANA HEALTH SCIENCES INC: 1632 units of Common Stock, dated 2026-10-22. The full Form 4 contains 3 transaction entries.
CRVO
De Rosch Mark reported Grant or award in CervoMed Inc.: 19100 units of Stock Option (Right to Buy) (derivative), dated 2026-10-22. The full Form 4 contains 1 transaction entry.
CRVO
Blackburn Kelly reported Grant or award in CervoMed Inc.: 19100 units of Stock Option (Right to Buy) (derivative), dated 2026-10-22. The full Form 4 contains 1 transaction entry.
ADC
Agree Joey reported Gift in AGREE REALTY CORP: 1150 units of Common Shares, dated 2026-10-21. The full Form 4 contains 2 transaction entries.
CRCL
Fox-Geen Jeremy reported Exercise or conversion in Circle Internet Group, Inc.: 15000 units of Class A Common Stock, dated 2026-10-21. The full Form 4 contains 3 transaction entries.
VLTO
Honeycutt Jennifer reported Exercise or conversion in Veralto Corp: 7098 units of Common Stock, dated 2026-10-23. The full Form 4 contains 3 transaction entries.
YELP
Schwarzbach David A reported Sale in YELP INC: 7500 units of Common Stock, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
BAC
Fitterling James R reported Grant or award in BANK OF AMERICA CORP /DE/: 2930.68 units of Phantom Stock (derivative), dated 2026-10-21. The full Form 4 contains 1 transaction entry.
SNTI
Rajangam Kanya reported Tax/exercise withholding in Senti Biosciences Holdings, Inc.: 19953 units of Common Stock, dated 2026-10-21. The full Form 4 contains 1 transaction entry.